• 한국초지조사료학회지
• /
• 제35권2호
• /
• pp.125-130
• /
• 2015

본 연구는 근적외선분광법을 이용하여 우리나라에서 재배되고 있는 목초류 중 외형적 특성이 유사한 이탈리안 라이그라스, 페레니얼 라이그라스와 톨 페스큐 종자의 초종판별 가능성을 검토하고자 수행되었다. 근적외선분광기를 이용하여 목초류 종자를 가시파장 대역대(680~1,099 nm), NIRS 파장 대역대(1,100-2,500 nm) 및 NIRS 전체 파장 대역대(680-2,500 nm)로 구분하여 스펙트라를 얻은 후 1차 미분과 8 nm gap으로 수 처리를 수행하였으며 부분최소자승(PLS) 회귀분석법을 통해 초종판별 검량식을 개발하고 판별 정확성을 검증하였다. 목초류의 초종판별 정확성은 가시파장대역에서 SECV 1.732, $R^2cv$ 0.96으로 가장 판별 정확성이 낮았으며 NIRS 전체 파장대역에서 SECV 1.182, $R^2cv$ 0.98로 가장 높은 판별 정확성을 나타내었다. 파장대역별 예측 정확성은 NIR 파장대역(1,100-2,500 nm)에서 교차검증오차(SECV) 1.319에서 예측 오차(SEP) 1.288로 낮아졌으며 가시영역대(680~1,099)는 SECV 1.732에서 SEP 1.749로 약간 높아졌다. Discrimination equation 분석법에 의한 NIRS 전체 파장대역별 목초류 초종의 판별 결과는 초종간에 판별 정확성의 차이가 크게 나타났으며 이탈리안 라이그라스의 'Hits'는 68%로 가장 낮았으며 페레니얼 라이그라스가 78%의 정확성으로 가장 높게 나타났다. 따라서 NIRS를 이용한 목초류 초종의 판별분석이 가능할 것으로 판단되었다.

• Journal of Pharmaceutical Investigation
• /
• 제35권3호
• /
• pp.137-142
• /
• 2005

A rapid, selective and sensitive reversed-phase HPLC method for the determination of glipizide in human serum was validated and applied to the pharmacokinetic study of glipizide. Glipizide and internal standard, tolbutamide, were extracted from human serum by liquid-liquid extraction with benzene and analyzed on a Nova Pak $C_{18}\;60{\AA}$ column with the mobile phase of acetonitrile-potassium dihydrogen phosphate (10 mM, pH 3.5) (4:6, v/v). Detection wavelength of 275 nm and flow rate of 0.7 ml/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^3$ factorial design using a fixed glipizide concentration (500 ng/ ml) with respect to its peak area and retention time. And also, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of 10-1000 ng/ml with correlation coefficient greater than 0.999. The lower limit of quantitation using 0.5 ml of serum was 10.0 ng/ml, which was sensitive enough for pharmacokinetic studies. The overall accuracy of the quality control samples ranged from 82.6 to 105.0% for glipizide with overall precision (% C.V.) being 1.13-13.20%. The percent recovery for human serum was in the range of 85.2 93.5%. Stability studies showed that glipizide was stable during storage, or during the assay procedure in human serum. The peak area and retention time of glipizide were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of glipizide in human serum samples for the pharmacokinetic studies at three different laboratories, demonstrating the suitability of the method.

• Journal of Pharmaceutical Investigation
• /
• 제35권6호
• /
• pp.437-443
• /
• 2005

A rapid, selective and sensitive reversed-phase HPLC method for the determination of a major metabolite of terfenadine, fexofenadine, in human serum was developed, validated, and applied to the pharmacokinetic study of terfenadine. Fexofenadine and internal standard, haloperidol were extracted from human serum by liquid-liquid extraction with acetonitrile and analyzed on a $Symmetry^{TM}$ C8 column with the mobile phase of 1% triethylamine phosphate (pH 3.7)-acetonitrile (67:33, v/v, adjusted to pH 5.6 with triethylamine). Detection wavelength of 230 nm for excitation, 280 nm for emission and flow rate of 1.0 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^{3}$ factorial design using a fixed fexofenadine concentration (50 ng/mL) with respect to its peak area and retention time. In addition, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of 10-500 ng/mL with correlation coefficients greater than 0.999. The lower limit of quantification using 0.5 mL of serum was 10 ng/mL, which was sensitive enough for the pharmacokinetic studies of terfenadine. The overall accuracy of the quality control samples ranged from 95.70 to 114.58% for fexofenadine with overall precision (% C.V.) being 3.53-14.39%. The relative mean recovery of fexofenadine for human serum was 90.17%. Stability studies (freeze-thaw, short-term, extracted serum sample and stock solution) showed that fexofenadine was stable during storage, or during the assay procedure in human serum. However, the storage at $-70^{\circ}C$ for 4 weeks showed that fexofenadine was not stable. The peak area and retention time of fexofenadine were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of fexofenadine in human serum samples for the pharmacokinetic studies of orally administered Tafedine tablet (60 mg as terfenadine) at three different laboratories, demonstrating the suitability of the method.

• Journal of Pharmaceutical Investigation
• /
• 제35권4호
• /
• pp.265-271
• /
• 2005

A rapid, selective and sensitive reversed-phase HPLC method for the determination of etodolac in human serum was developed, validated, and applied to the pharmacokinetic study of etodolac. Etodolac and internal standard, ibuprofen were extracted from human serum by liquid-liquid extraction with hexane/isopropanol (95:5, v/v) and analyzed on a Luna C18(2) column with the mobile phase of 1% aqueous acetic acid-acetonitrile (4:6, v/v). Detection wavelength of 227 nm and flow rate of 1.0 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^3$ factorial design using a fixed etodolac concentration $(1\;{\mu}g/mL)$ with respect to its peak area and retention time. And also, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of $0.05-40\;{\mu}g/mL$ with correlation coefficients greater than 0.999. The lower limit of quantification using 0.5 mL of serum was 0.05 ${\mu}g/mL$, which was sensitive enough for pharmacokinetic studies. The overall accuracy of the quality control samples ranged from 92.00 to 110.00% for etodolac with overall precision (% C.V.) being 1.08-10.11%. The percent recovery for human serum was in the range of 76.73-115.30%. Stability studies showed that etodolac was stable during storage, or during the assay procedure in human serum. The peak area and retention time of etodolac were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of etodolac in human serum samples for the pharmacokinetic studies of orally administered Lodin XL tablet (400 mg as etodolac) at three different laboratories, demonstrating the suitability of the method.

• Journal of Pharmaceutical Investigation
• /
• 제35권6호
• /
• pp.423-429
• /
• 2005

A selective and sensitive reversed-phase HPLC method for the determination of fenoprofen in human serum was developed, validated, and applied to the pharmacokinetic study of fenoprofen calcium. Fenoprofen and internal standard, ketoprofen, were extracted from human serum by liquid-liquid extraction with diethyl ether and analyzed on a Luna C18(2) column with the mobile phase of acetonitrile-3 mM potassium dihydrogen phosphate (32:68, v/v, adjusted to pH 6.6 with phosphoric acid). Detection wavelength of 272 nm and flow rate of 0.25 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^{3}$ factorial design using a fixed fenoprofen concentration $(2\;{\mu}g/mL)$ with respect to its peak area and retention time. And also, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of $0.05-100\;{\mu}g/mL$ with correlation coefficients greater than 0.999. The lower limit of quantification using 1 mL of serum was $0.05\;{\mu}g/mL$, which was sensitive enough for pharmacokinetic studies. The overall accuracy of the quality control samples ranged from 92.27 to 109.20% for fenoprofen with overall precision (% C.V.) being 5.51-11.71 %. The relative mean recovery of fenoprofen for human serum was 81.7%. Stability (freeze-thaw, short and long-term) studies showed that fenoprofen was not stable during storage. But, extracted serum sample and stock solution were allowed to stand at ambient temperature for 12 hr prior to injection without affecting the quantification. The peak area and retention time of fenoprofen were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of fenoprofen in human serum samples for the pharmacokinetic studies of orally administered Fenopron tablet (600 mg as fenoprofen) at three different laboratories, demonstrating the suitability of the method.

• Journal of Astronomy and Space Sciences
• /
• 제12권1호
• /
• pp.21-29
• /
• 1995

$\beta$ Lyrae형 식쌍성 AW Cam을 UBV 세파장 영역에서 광전 관측하여 얻은 UBV 광도곡선을 Wilson and Devinney 쌍성 모델의 2가지 mode( mode 2와 mode 5)로 분석하였다. 이는 Russo and Milano (1983)가 산출한 측광 질량비(q=0.21)와 Mammano et al. (1967)의 분광질량비(q=0.43)가 일치하지 않는 모순-AW Cam 계의 남아 있는 문제인-올 해결하기 위한 것이다. Mode 2로 구한 측광학적 해가 mode 5로 구한 해보다 관측된 광도곡선을 더 잘 반영하는 것으로 계산되었다. 이는AW Cam이 정상준분리형계가 아나라 분리형 쌍성계임을 제시하는 것으로 해석될 수 있다. 또한 산출한 질량비 (q=0.43)로 계산한 AW Cam계의 삼차원 로쉬 모형을 보면 가벼운 반성은 안쪽 로쉬 한계면에 잘 들어 있는 반연 더 무거운 주성이 로쉬 한계면에 거의 접촉하고 있다. 로쉬 기하, 공전주기의 일정성, 그리고 다른 측광학적 증거들로 부터 AW Cam은 Giuricin and Mardrossian (1981)이 제안한 ‘접촉이 깨진 상태’에 있는 진화된 분리형 쌍성계가 아니라, ‘접촉 상태’로 가고 있는case A 진화 상 태에 있는 덜 진화된 분리형 쌍성계로 잠정적으로 결론짓는다

• 한국전자파학회논문지
• /
• 제8권2호
• /
• pp.185-196
• /
• 1997

본 논문에서는 SAR에 대한 개념 및 이론, 해상도에 대한 정의 및 웅용분야를 통해 SAR 설계 및 분석시 필수 적인 사항을 고찰하였다. 방위 해상도를 구하는 3가지 기볍인 실개구면, Unfocused 및 Focused 기법의 해상도 성취능력에 대해 시율레이션을 통하여 비교 분석하였다. 신호처리 계산량에 대한 부담이 적고 저가의 비용으로 구현이 가능한 Unfocused 기법을 적용할 수 있는 제한 된 조건을 도출하기 위하여 시율레이션을 수행하였다. 본 논문에서 설정한 SAR 영상의 용도는 재난피해 파악 동의 민수분야 및 전술적인 목적의 군수분야 둥과 같이 제한된 구역의 전반적인 상황을 판단하는데 적용하는 것 이다. 이러한용도로사용할수있는SAR플랫폼으로RPV및 중소형 항공기가선정되었으며, 해상도가5-15 m라는 것을 알 수 있었다. 시율레이션을 통하여 관련 변수들을 trade-off한 결과 이 임무에 적합한 범위가 레이 다 거리는 3,000 m 이하, 파장은 0.024-0.3 m, 개구면 길이는 1-10 m였으며, 이러한 제한된 조건에서 두 개의 점표적에 대한 3가지 기볍의 원 신호 및 신호처리 결과를 보였다. 따라서 본 논문에서 제시한 결과는 원거리에서 소규모 표적식별과 같이 고정밀도의 해상도가 요구되는 분야이 외에 제한된 조건에서는 Unfocused 기법을 활용하는 것이 몇가지 측면에서 유용하다는 것올 제시하였다.

• 한국항해항만학회:학술대회논문집
• /
• 한국항해항만학회 2019년도 추계학술대회
• /
• pp.150-152
• /
• 2019

본 연구에서는 3차원 수치조파수조기법을 이용하여 연안 구조물로 인한 파동장의 변화가 진동수주 파력발전장치의 유체동역학적 성능에 미치는 영향에 대한 분석을 수행하였다. 진동수주 파력발전장치는 선형 압력강하모델을 도입을 통해 시간에 따른 터빈-진동수주실간의 연성효과를 고려하여 수치적으로 모사하였다. 방파제 모델의 고려유무에 따라 반사특성의 변화로 인해 진동수주실 주변의 유동분포는 서로 다른 것으로 나타났다. 방파제로부터 포획된 파랑에너지는 방파제 전면의 평면상에 공간적으로 분포되었는데, 진동수주실 전면에 집중된 경우에 변환된 공력발전량은 급격히 높아졌다. 정상파 분포의 변화는 입사파장과 방파제의 길이의 관계에 따라 반복적으로 나타났으며, 이로 인한 진동수주실의 에너지변환 성능의 차이를 확인하였다.

• Journal of Pharmaceutical Investigation
• /
• 제36권1호
• /
• pp.45-51
• /
• 2006

A rapid, selective and sensitive reversed-phase HPLC method for the determination of dipyridamole in human serum was developed, validated, and applied to the pharmacokinetic study of dipyridamole. Dipyridamole and internal standard, loxapine, were extracted from human serum by liquid-liquid extraction with diethyl ether and analyzed on a Nova Pak $C_{I8}$ column with the mobile phase of 40 mM ammonium acetate:methanol:acetonitrile (35:35:30)(v/v/v, pH 7.8). Detection wavelength of 280 nm and flow rate of 1.0 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^3$ factorial design using a fixed dipyridamole concentration (50 ng/mL) with respect to its peak area and retention time. And also, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of 2-2000 ng/mL with correlation coefficients greater than 0.999. The lower limit of quantification using 0.5 mL of serum was 2 ng/mL, which was sensitive enough for pharmacokinetic studies of dipyridamole. The overall accuracy of the quality control samples ranged from 103.94 to 105.86% for dipyridamole with overall precision (% C.V.) being 4.60-11.49%. The relative mean recovery of dipyridamole for human serum was 97.64%. Stability studies showed that dipyridamole was stable during storage, or during the assay procedure in human serum. The peak area and retention time of dipyridamole were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of dipyridamole in human serum samples for the pharmacokinetic studies of orally administered Dimor tablet (75 mg as dipyridamole) at three different laboratories, demonstrating the suitability of the method.

• Journal of Pharmaceutical Investigation
• /
• 제36권1호
• /
• pp.23-29
• /
• 2006

A rapid, selective and sensitive reversed-phase HPLC method for the determination of promethazine in human serum was developed, validated, and applied to the pharmacokinetic study of promethazine. Promethazine and internal standard, chlorpromazine, were extracted from human serum by liquid-liquid extraction with n-hexane containing 0.8% isopropanol and analyzed on a Capcell Pak CN column with the mobile phase of acetonitrile-0.2 M potassium dihydrogen phosphate (42:58, v/v, adjusted to pH 6.0 with 1 M NaOH). Detection wavelength of 251 nm and flow rate of 0.9 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^{3}$ factorial design using a fixed promethazine concentration (10 ng/mL) with respect to its peak area and retention time. In addition, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of 1-40 ng/mL with correlation coefficients greater than 0.999. The lower limit of quantification using 1 mL of serum was 1 ng/mL, which was sensitive enough for pharmacokinetic studies. The overall accuracy of the quality control samples ranged from 96.15 to 105.40% for promethazine with overall precision (% C.V.) being 6.70-11.22%. The relative mean recovery of promethazine for human serum was 63.54%. Stability (freeze-thaw and short-term) studies showed that promethazine was stable during storage, or during the assay procedure in human serum. However, the storage at $-80^{\circ}C$ for 4 weeks showed that promethazine was not stable. Extracted serum sample and stock solution were not allowed to stand at ambient temperature for 12 hr prior to injection. The peak area and retention time of promethazine were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of promethazine in human serum samples for the pharmacokinetic studies of orally administered Himazin tablet (25 mg as promethazine hydrochloride) at three different laboratories, demonstrating the suitability of the method.